EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk Factors for the Recurrence of Massive Hemoptysis Treated With Bronchial Artery Embolization: A Retrospective Study

Tianhua Yue iD, Ling Li, Zhengyu Yue

The Clinical Respiratory Journal · 2026-05 · 20 (5)

DOI: 10.1111/crj.70187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, online erschienen am 27.04.2026. Verfasst von Tianhua Yue und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Yancheng First Hospital Affiliated of Nanjing University Medical College, Yancheng, Jiangsu, China. Hauptthemen laut MEDLINE: Hemoptysis, Embolization, Therapeutic, Bronchial Arteries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bronchial artery embolization (BAE) is preferred for massive hemoptysis. However, the suboptimal short‐term and long‐term therapeutic outcomes have necessitated the initiation of this study. The aim of this study was to identify risk factors that influence the recurrence of massive hemoptysis after BAE and determine active prevention and control measures to reduce recurrence.

Methods

Between January 2019 and November 2024, a total of 162 patients with massive hemoptysis underwent BAE, of whom 47 required re‐embolization due to recurrence. Baseline data of patients, technical success, clinical success, recurrence, complications, and other relevant information were collected from outpatient and inpatient medical records and subsequently analyzed. The Cox regression analysis and Forest map were employed to analyze the risk factors associated with recurrence of massive hemoptysis after BAE.

Results

Findings suggested that the technical success rate was (160/162) 98.76% and clinical success rate was (115/162) 70.99% during the 12‐month follow‐up. Mean recurrence‐free time was 26 ± 3.43 days (95% CI: 19.28–32.72) among 47 patients who experienced recurrence following BAE. Multivariate Cox regression analysis showed that the risk factors for early recurrence of hemoptysis following BAE were the extent of destroyed lung (OR = 0.562 [95% CI: 0.325–0.973], p = 0.04), whether preoperative computed tomography angiography (CTA) (OR = 0.204 [95% CI: 0.083–0.499], p = 0.001), or technical factors (OR = 4.621 [95% CI: 1.936–11.028], p = 0.001), while the risk factor for late recurrence was the progression of underlying diseases (OR = 6.071 [95% CI: 1.968–18.731], p = 0.002). However, the overall risk factors for recurrent hemoptysis after BAE included the extent of destroyed lung (OR = 0.606 [95% CI: 0.404–0.91], p = 0.016), whether preoperative CTA (OR = 0.49 [95% CI: 0.266–0.905], p = 0.023), technical factors (OR = 2.176 [95% CI: 1.089–4.348], p = 0.028), and the progression of underlying diseases (OR = 1.958 [95% CI: 1.047–3.662], p = 0.035. There were no major complications related to BAE requiring immediate treatment, and only minor complications were observed.

Conclusion

This study preliminarily concludes that the extent of destroyed lung, whether preoperative CTA, technical factors, and the progression of underlying diseases are independent risk factors associated with hemoptysis recurrence after BAE. Through comprehensive preoperative assessments, individualized embolization strategies, and proactive postoperative management of underlying diseases, the risk of recurrent hemoptysis can be significantly reduced.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemoptysisEmbolization, TherapeuticBronchial ArteriesHumansFemaleMaleRetrospective StudiesRisk FactorsRecurrenceMiddle AgedTreatment OutcomeAdultAged

Stichwörter der Autor:innen

CT angiographybronchial artery embolizationmassive hemoptysisrecurrence

Autor:innen und Institutionen

  • Department of Interventional Radiology, Yancheng First Hospital Affiliated of Nanjing University Medical College, Yancheng, Jiangsu, China.
  • Jiangsu Medical College, Yancheng, Jiangsu, China.
  • Department of Interventional Radiology, Jianhu County People's Hospital, Jianhu, Jiangsu, China.
  • First School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.

ORCID-Profile: Tianhua Yue

Förderung

  • Jiangsu Medical College

Zitieren

APA

Yue, T., Li, L., & Yue, Z. (2026). Risk Factors for the Recurrence of Massive Hemoptysis Treated With Bronchial Artery Embolization: A Retrospective Study. The Clinical Respiratory Journal, 20(5). https://doi.org/10.1111/crj.70187

Vancouver

Yue T, Li L, Yue Z. Risk Factors for the Recurrence of Massive Hemoptysis Treated With Bronchial Artery Embolization: A Retrospective Study. The Clinical Respiratory Journal. 2026;20(5). doi:10.1111/crj.70187

BibTeX
@article{Yue2026,
  author = {Yue, Tianhua and Li, Ling and Yue, Zhengyu},
  title = {Risk Factors for the Recurrence of Massive Hemoptysis Treated With Bronchial Artery Embolization: A Retrospective Study},
  journal = {The Clinical Respiratory Journal},
  year = {2026},
  volume = {20},
  number = {5},
  doi = {10.1111/crj.70187}
}
Kostenlos starten →